From: Overactive bladder symptoms recurrence after sudden versus gradual weaning of Solifenacin
Symptoms Recurrence | P value | ||
---|---|---|---|
No N = 48 | Yes N = 12 | ||
Treatment Protocol; n (%) | |||
Group I; n = 30 | 20 (66.7) | 10 (33.3) | 0.001* |
Group II; n = 30 | 28 (93.3) | 2 (6.7) | |
Age; (years) | |||
qMean ± SD | 40.04 ± 17.4 | 61.67 ± 12.1 | 0.001* |
95% CI1 for Mean | |||
Lower bound | 35.00 | 54.00 | |
Upper bound | 45.08 | 69.32 | |
Range (Max–Min) | 65.00 (75–10) | 35.00 (77–42) | |
Gender; n (%) | |||
Male; n = 21 | 18 (85.7) | 3 (14.3) | 0.325a |
Female; n = 39 | 30 (76.9) | 9 (23.1) |